摘要:
Novel therapeutic agents useful as inhibitors of HLE are provided. The compounds have structural formula (I) wherein R through R , m, n and p are as defined herein. Methods of using the compounds of formula (I) to inhibit serine proteases and to treat physiological conditions and disease states associated with elevated HLE levels are also provided, as are pharmaceutical compositions containing the compounds.